(19)
(11) EP 1 140 155 A1

(12)

(43) Date of publication:
10.10.2001 Bulletin 2001/41

(21) Application number: 99966613.4

(22) Date of filing: 22.12.1999
(51) International Patent Classification (IPC)7A61K 39/00, A61K 39/29, A61K 39/295, A61K 45/00, C07K 14/00, C12N 15/09
(86) International application number:
PCT/US9930/770
(87) International publication number:
WO 0037/104 (29.06.2000 Gazette 2000/26)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 23.12.1998 US 113400 P

(71) Applicant: Merck & Co., Inc.
Rahway,New Jersey 07065-0907 (US)

(72) Inventors:
  • ZHAO, Qinjian
    Rahway, NJ 07065-0907 (US)
  • SITRIN, Robert
    Rahway, NJ 07065-0907 (US)
  • ABRAHAM, Dicky, G.
    Rahway, NJ 07065-0907 (US)
  • GERVAIS, David, P.
    Rahway, NJ 07065-0907 (US)
  • GIMINEZ, Juan
    Rahway, NJ 07065-0907 (US)

(74) Representative: Horgan, James Michael Frederic 
Merck & Co., Inc.,Terlings Park,Eastwick Road
Harlow,Essex CM20 2QR
Harlow,Essex CM20 2QR (GB)

   


(54) IMPROVED RECOMBINANT HEPATITIS B SURFACE ANTIGEN